Search

everythinglearnresearchcommunity

for

Search:↓

Educating primary care doctors and improving referrals to rheumatologists can reduce delays in treating lupus patients.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

RANKL is crucial for bone health, immune function, and other body processes.

LncRNAs play a crucial role in muscle regulation and could help develop treatments for Duchenne muscular dystrophy.

Platelet-rich concentrates can be an alternative treatment for oral lichen planus, especially when steroids don't work.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Strict regulations may slow down new LLLT treatments.

The gene causing hair loss and heart issues in rough coat mice is still unknown.

Certain RNAs may help diagnose alopecia areata by affecting keratin genes.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Kawasaki Disease is rare and often missed in adults, who show different symptoms than children, and may benefit from early treatment.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

Platelet-rich plasma treatments reduce knee osteoarthritis inflammation, with pure PRP being more effective.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

Loose anagen hair syndrome in children often resolves on its own.

Using Lasswell's model can make CSR communication more effective and trusted.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Human tissue kallikreins help regulate skin barrier functions and affect skin health.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Different long non-coding RNAs in yaks change during hair growth cycles and are involved in key growth pathways.

The gene LRRC15 is more active in balding areas of the scalp compared to non-balding areas.

A boy developed a rare skin condition after recovering from a severe skin reaction, and it improved with lotion treatment.